Zhukov AD. N-stearoylethanolamine effect on the level of 11-hydroxycorticosteroids, cytokines IL-1?,. The Ukrainian Biochemical Journal. 2014;86(3):88–97.
2.
Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World Journal of Diabetes. 2015;6(3):456.
3.
Al-Mahmood A, Afrin S, Hoque N. Dyslipidemia in Insulin Resistance: Cause or Effect. Bangladesh Journal of Medical Biochemistry. 7(1):27–31.
4.
Jung H, Chae H. The Safety and Efficacy of Methocarbamol as a Muscle Relaxant with Analgesic Action: Analysis of Current Data. Innovative Biosystems and Bioengineering. 3(4):201–11.
5.
Raphael W, Sordillo L. Dietary Polyunsaturated Fatty Acids and Inflammation: The Role of Phospholipid Biosynthesis. International Journal of Molecular Sciences. 14(10):21167–88.
6.
Gula NM, Goridko TM, Stogniy NA, Klymashevsky VM, Meged OF, Kosyakova GV, et al. Protective effect of n-stearoylethanolamine under acute alcohol intoxication in rats. Ukr Biochem J. 2010;82(2):42–52.
7.
Andreieva S, Korets K. Results of Cytogenetic and Molecular Cytogenetic Studies in Relapce/Refractory of Multiple Myeloma. Innovative Biosystems and Bioengineering. 2(4):213–20.
8.
Galkin OYu, Savchenko AA, Nikitina KI, et al. Obtaining and study of properties of new monoclonal antibodies against human IgЕ. The Ukrainian Biochemical Journal. 2013;85(6):81–7.
9.
Galkin OYu, Lutsenko TM, Gorshunov YuV, et al. Development of the method for microbiological purity testing of recombinant human interleukin-7-based product. The Ukrainian Biochemical Journal. 2017;89(3):52–9.
10.
Onopchenko OV. The effect of N-stearoylethanolamine on the activity of antioxidant enzymes, content of lipid peroxidation products and nitric oxide in the blood plasma and liver of rats with induced insulin-resistance. The Ukrainian Biochemical Journal. 2013;85(6):88–96.
Yang X, Zhang S, Dong Z, Zi Y, Luo Y, Jin Z, et al. Insulin Resistance Is a Risk Factor for Overall Cerebral Small Vessel Disease Burden in Old Nondiabetic Healthy Adult Population. Frontiers in Aging Neuroscience. 11.
13.
Lim H, Müller N, Herold MJ, Van Den Brandt J, Reichardt HM. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology. 2007;122(1):47–53.
14.
Galkin OYu, Gorshunov YuV, Besarab OB, et al. Development and characterization of highly informative ELISA for the detection of IgG and IgA antibodies to Сhlamydia trachomatis. The Ukrainian Biochemical Journal. 2018;90(3):70–83.
15.
Goridko TM, Kosiakova GV, Berdyschev AG, Bazylyanska VR, Margitich VM, Gula NM. The influence of N-stearoylethanolamine on the activity of antioxidant enzymes and on the level of stable NO metabolites in the rat testes and blood plasma at the early stages of streptozotocine-іnduced diabetes. Ukr Biochem J. 2012;84(3):37–43.
16.
Velkov. Free fatty acids: the new marker of insulin resistance and ischemia. Laboratornaia diagnostika. 2009;3(49):55-71.
17.
Galkin OYu, Besarab AB, Lutsenko TN. Characteristics of enzyme-linked immunosorbent assay for detection of IgG antibodies specific to Сhlamydia trachomatis heat shock protein (HSP-60). The Ukrainian Biochemical Journal. 2017;89(1):22–30.
18.
Rull A, Camps J, Alonso-Villaverde C, Joven J. Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism. Mediators of Inflammation. 2010;2010:1–11.
19.
Onopchenko OV. The effect of N-stearoylethanolamine on plasma lipid composition in rats with experimental insulin resistance. The Ukrainian Biochemical Journal. 2015;87(1):46–54.
20.
Zhou H, Urso CJ, Jadeja V. <p>Saturated Fatty Acids in Obesity-Associated Inflammation</p> Journal of Inflammation Research. Volume 13:1–14.
21.
Galkin OYu, Komar AG, Besarab OB. Different mice inbred strains humoral immune response against human prostate-specific antigen. The Ukrainian Biochemical Journal. 2019;91(1):30–7.
22.
Onopchenko OV. The effect of N-stearoylethanolamine on cholesterol content, fatty acid composition and protein carbonylation level in rats with alimentary obesity-induced insulin resistance. The Ukrainian Biochemical Journal. 2014;86(6):119–28.
23.
Bruun S, Gouveia-Figueira S, Domellöf M, Husby S, Neergaard Jacobsen L, Michaelsen KF, et al. Satiety Factors Oleoylethanolamide, Stearoylethanolamide, and Palmitoylethanolamide in Mother’s Milk Are Strongly Associated with Infant Weight at Four Months of Age—Data from the Odense Child Cohort. Nutrients. 10(11):1747.
24.
Duong TV, Shih CK, Wong TC, Chen HH, Chen TH, Hsu YH, et al. Insulin Resistance and Cardiovascular Risks in Different Groups of Hemodialysis Patients: A Multicenter Study. BioMed Research International. 2019;2019:1–9.
25.
Robins SJ, Lyass A, Zachariah JP, Massaro JM, Vasan RS. Insulin Resistance and the Relationship of a Dyslipidemia to Coronary Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011;31(5):1208–14.
26.
Hula NM. Fatty Acids and Their Derivatives in Pathologic States. 2009.
27.
Morigny P, Houssier M, Mouisel E, Langin D. Adipocyte lipolysis and insulin resistance. Biochimie. 2016;125:259–66.
28.
Klevebro S, Juul SE, Wood TR. A More Comprehensive Approach to the Neuroprotective Potential of Long-Chain Polyunsaturated Fatty Acids in Preterm Infants Is Needed—Should We Consider Maternal Diet and the n-6:n-3 Fatty Acid Ratio? Frontiers in Pediatrics. 7.
29.
Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, et al. Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association. Journal of Clinical Lipidology. 2013;7(4):304–83.
30.
Deedwania P. Hypertension, Dyslipidemia, and Insulin Resistance in Patients With Diabetes Mellitus or the Cardiometabolic Syndrome: Benefits of Vasodilating β‐Blockers. The Journal of Clinical Hypertension. 2011;13(1):52–9.
31.
Coelho M, Oliveira T, Fernandes R. State of the art paper Biochemistry of adipose tissue: an endocrine organ. Archives of Medical Science. 2013;2:191–200.
32.
Akbari M, Hassan-Zadeh V. IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology. 2018;26(3):685–98.
33.
Matias I, Gonthier M, Petrosino S, Docimo L, Capasso R, Hoareau L, et al. Role and regulation of acylethanolamides in energy balance: focus on adipocytes and β‐cells. British Journal of Pharmacology. 2007;152(5):676–90.
34.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87(1):4–14.
35.
Glass CK, Olefsky JM. Inflammation and Lipid Signaling in the Etiology of Insulin Resistance. Cell Metabolism. 2012;15(5):635–45.
36.
Grigorieva SM, Starosyla DB, Rybalko SL, et al. Effect of recombinant human interleukin-7 on Pseudomonas aeruginosa wound infection. The Ukrainian Biochemical Journal. 2019;91(5):7–15.
37.
Peritore AF, Siracusa R, Crupi R, Cuzzocrea S. Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets. Nutrients. 11(9):2175.
38.
Lutsenko TN, Kovalenko MV, Galkin OYu, et al. Validation of biological activity testing procedure of recombinant human interleukin-7. The Ukrainian Biochemical Journal. 2017;89(1):82–9.
39.
Herheliuk T, Perepelytsina O, Ostapchenko L, Sydorenko M. Effect of Interferon α-2b on Multicellular Tumor Spheroids of MCF-7 Cell Line Enriched with Cancer Stem Cells. Innovative Biosystems and Bioengineering. 3(1):34–44.
40.
Shi J, Fan J, Su Q, Yang Z. Cytokines and Abnormal Glucose and Lipid Metabolism. Frontiers in Endocrinology. 10.
41.
Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes & Development. 2007;21(12):1443–55.
42.
Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. The American Journal of Cardiology. 1999;83(9):25–9.
43.
SALEH S, EL-MARAGHY N, REDA E, BARAKAT W. Modulation of Diabetes and Dyslipidemia in Diabetic Insulin-Resistant Rats by Mangiferin: Role of Adiponectin and TNF-α. Anais da Academia Brasileira de Ciências. 2014;86(4):1935–48.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
